|
1
|
McGregor ML, Bremer DL, Cole C, McClead
RE, Phelps DL, Fellows RR and Oden N: HOPE-ROP Multicenter Group.
High Oxygen Percentage in Retinopathy of Prematurity study:
Retinopathy of prematurity outcome in infants with prethreshold
retinopathy of prematurity and oxygen saturation >94% in room
air: The high oxygen percentage in retinopathy of prematurity
study. Pediatrics. 110:540–544. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sola A, Chow L and Rogido M: Retinopathy
of prematurity and oxygen therapy: A changing relationship. An
Pediatr (Barc). 62:48–63. 2005.(In spanish). PubMed/NCBI
|
|
3
|
Chamney S, McGrory L, McCall E, Twaij S,
Napier M, Rollins R, Marshall AH, Craig S and McLoone E: Treatment
of retinopathy of prematurity in Northern Ireland, 2000–2011: A
population-based study. J AAPOS. 19:223–227. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Levesque BM, Kalish LA, Winston AB, Parad
RB, Hernandez-Diaz S, Phillips M, Zolit A, Morey J, Gupta M,
Mammoto A, et al: Low urine vascular endothelial growth factor
levels are associated with mechanical ventilation, bronchopulmonary
dysplasia and retinopathy of prematurity. Neonatology. 104:56–64.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Patel S Jivabhai, Bany-Mohammed F, McNally
L, Valencia GB, Lazzaro DR, Aranda JV and Beharry KD: Exogenous
superoxide dismutase mimetic without scavenging
H2O2 causes photoreceptor damage in a rat
model for oxygen-induced retinopathy. Invest Ophthalmol Vis Sci.
56:1665–1677. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Penn JS, Tolman BL and Henry MM:
Oxygen-induced retinopathy in the rat: Relationship of retinal
nonperfusion to subsequent neovascularization. Invest Ophthalmol
Vis Sci. 35:3429–3435. 1994.PubMed/NCBI
|
|
7
|
Smith LE, Wesolowski E, McLellan A, Kostyk
SK, D'Amato R, Sullivan R and D'Amore PA: Oxygen-induced
retinopathy in the mouse. Invest Ophthalmol Vis Sci. 35:101–111.
1994.PubMed/NCBI
|
|
8
|
Sato T, Kusaka S, Hashida N, Saishin Y,
Fujikado T and Tano Y: Comprehensive gene-expression profile in
murine oxygen-induced retinopathy. Br J Ophthalmol. 93:96–103.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bentwich I, Avniel A, Karov Y, Aharonov R,
Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al:
Identification of hundreds of conserved and nonconserved human
microRNAs. Nat Genet. 37:766–770. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie M, Zhang S and Yu B: microRNA
biogenesis, degradation and activity in plants. Cell Mol Life Sci.
72:87–99. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Doench JG and Sharp PA: Specificity of
microRNA target selection in translational repression. Genes Dev.
18:504–511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kuhnert F, Mancuso MR, Hampton J,
Stankunas K, Asano T, Chen CZ and Kuo CJ: Attribution of vascular
phenotypes of the murine Egfl7 locus to the microRNA miR-126.
Development. 135:3989–3993. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y and Gorski DH: Regulation of
angiogenesis through a microRNA (miR-130a) that down-regulates
antiangiogenichomeobox genes GAX and HOXA5. Blood. 111:1217–1226.
2008.PubMed/NCBI
|
|
14
|
Kuehbacher A, Urbich C, Zeiher AM and
Dimmeler S: Role of Dicer and Drosha for endothelial microRNA
expression and angiogenesis. Circ Res. 101:59–68. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johnson CD, Esquela-Kerscher A, Stefani G,
Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J,
Shingara J, et al: The let-7 microRNA represses cell proliferation
pathways in human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen J, Yang X, Xie B, Chen Y, Swaim M,
Hackett SF and Campochiaro PA: MicroRNAs regulate ocular
neovascularization. Mol Ther. 16:1208–1216. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bai Y, Bai X, Wang Z, Zhang X, Ruan C and
Miao J: MicroRNA-126 inhibits ischemia-induced retinal
neovascularization via regulating angiogenic growth factors. Exp
Mol Pathol. 91:471–477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C (T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang W, Li Z, Sato T and Oshima Y:
Tenomodulin inhibits retinal neovascularization in a mouse model of
oxygen-induced retinopathy. Int J Mol Sci. 13:15373–15386. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia C, Cai Y, Lin Y, Guan R, Xiao G and
Yang J: MiR-133b-5p regulates the expression of the heat shock
protein 70 during rat neuronal cell apoptosis induced by the gp120
V3 loop peptide. J Med Virol. 88:437–447. 2015.PubMed/NCBI
|
|
21
|
Rérole AL, Jego G and Garrido C: Hsp70:
Anti-apoptotic and tumorigenic protein. Methods. 787:205–230.
2011.
|
|
22
|
Zhao H, Li M, Li L, Yang X, Lan G and
Zhang Y: MiR-133b is down-regulated in human osteosarcoma and
inhibits osteosarcoma cells proliferation, migration, and invasion
and promotes apoptosis. PLoS One. 8:e835712013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Noh SJ, Miller SH, Lee YT, Goh SH,
Marincola FM, Stroncek DF, Reed C, Wang E and Miller JL: Let-7
microRNAs are developmentally regulated in circulating human
erythroid cells. J Transl Med. 7:982009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Landskroner-Eiger S, Moneke I and Sessa
WC: miRNAs as modulators of angiogenesis. Cold Spring Harb Perspect
Med. 3:a0066432013.PubMed/NCBI
|
|
25
|
Vaz F, Hanenberg H, Schuster B, Barker K,
Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, et al:
Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat
Genet. 42:406–409. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang S, Tang Y, Cui H, Zhao X, Luo X, Pan
W, Huang X and Shen N: Let-7/miR-98 regulate Fas and Fas-mediated
apoptosis. Genes Immun. 12:149–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ulivi P, Foschi G, Mengozzi M, Scarpi E,
Silvestrini R, Amadori D and Zoli W: Peripheral Blood mir-328
expression as a potential biomarker for the early diagnosis of
NSCLC. Int J Mol Sci. 14:10332–10342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arora S, Ranade AR, Tran NL, Nasser S,
Sridhar S, Korn RL, Ross JT, Dhruv H, Foss KM, Sibenaller Z, et al:
MicroRNA-328 is associated with (non-small) cell lung cancer
(NSCLC) brain metastasis and mediates NSCLC migration. Int J
Cancer. 129:2621–2631. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Okumus NO, Gursel B, Meydan D, Ozdemir O,
Odabas E and Gonullu G: Prognostic significance of concomitant
radiotherapy in newly diagnosed glioblastomamultiforme: A
multivariate analysis of 116 patients. Ann Saudi Med. 32:250–255.
2012.PubMed/NCBI
|
|
30
|
Delic S, Lottmann N, Stelzl A, Liesenberg
F, Wolter M, Götze S, Zapatka M, Shiio Y, Sabel MC, Felsberg J, et
al: MiR-328 promotes glioma cell invasion via SFRP1-dependent
Wnt-signaling activation. Neuro Oncol. 16:179–190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brafman A, Mett I, Shafir M, Gottlieb H,
Damari G, Gozlan-Kelner S, Vishnevskia-Dai V, Skaliter R, Einat P,
Faerman A, et al: Inhibition of oxygen-induced retinopathy in
RTP801-deficient mice. Invest Ophthalmol Vis Sci. 45:3796–3805.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nidadavolu LS, Niedernhofer LJ and Khan
SA: Identification of microRNAs dysregulated in cellular senescence
driven by endogenous genotoxicstress. Aging (Albany NY). 5:460–473.
2013.PubMed/NCBI
|
|
34
|
Huang JY, Chou SF, Lee JW, Chen HL, Chen
CM, Tao MH and Shih C: MicroRNA-130a can inhibit hepatitis B virus
replication via targeting PGC1α and PPARγ. RNA. 21:385–400. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tawfik A, Sanders T, Kahook K, Akeel S,
Elmarakby A and Al-Shabrawey M: Suppression of retinal peroxisome
proliferator-activated receptor gamma in experimental diabetes and
oxygen-induced retinopathy: Role of NADPH oxidase. Invest
Ophthalmol Vis Sci. 50:878–884. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Simpson-Haidaris PJ, Pollock SJ, Ramon S,
Guo N, Woeller CF, Feldon SE and Phipps RP: Anticancer role of
PPARgamma agonists in hematological malignancies found in the
vasculature, marrow and eyes. PPAR Res. 2010:8146092010.PubMed/NCBI
|
